A Phase 2, Randomized, Double Blind, Study of Intravenous TD 1792 Versus Vancomycin for Treatment of Complicated Gram Positive Skin and Skin Structure Infections.
Phase of Trial: Phase II
Latest Information Update: 29 Sep 2014
At a glance
- Drugs Cefilavancin (Primary) ; Aztreonam; Metronidazole; Vancomycin
- Indications Gram-positive infections; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors Theravance
- 06 Aug 2012 Results published in Antimicrobial Agents and Chemotherapy.
- 05 Jan 2007 New trial record.